检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:雷霄[1] 赵文锐[1] 梁英魁[1] Lei Xiao Zhao Wenrui Liang Yingkui(Department of Nuclear Medicine, Navy General Hospital, Beijing 100048, China)
出 处:《中华核医学与分子影像杂志》2017年第10期660-663,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging
摘 要:乳腺癌是女性常见肿瘤之一,近年其发病率逐步上升.随着诊疗技术的进展,可以根据乳腺癌分子分型,个体化、规范化地针对乳腺癌患者展开精准治疗,其中靶向治疗药物是精准治疗的重要研究方向.如何有效地对靶向治疗进行合理评估是关注的重点.PET/CT在乳腺癌的诊断、分期、治疗方案确定、疗效评价、预后评估及随访方面起着重要的作用.笔者就PET/CT在乳腺癌靶向药物治疗中的应用予以综述.Breast cancer is one of the most common malignant tumors in women, and its morbidity is increasing gradually in recent years. Precision treatment has been developed with individualized and standardized protocols according to the molecular classification of breast cancer. Targeted therapy is one of the most important methods. How to evaluate targeted therapy is the focus of attention. PET/CT plays an im-portant role in the diagnosis, staging, treatment plan and evaluation of therapeutic effect and prognosis, es-pecially in targeted therapy of breast cancer. This review summarizes the applications of PET/CT in targeted therapy of breast cancer.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.117.106.206